Erratum: Correction: Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Bortezomib and Hypoxia-Activated Prodrug TH-302, In Vivo and In Vitro (Mol Cancer Ther (2013) 12 (1763-73))

Jinsong Hu; Els Van Valckenborgh; Dehui Xu; Eline Menu; Hendrik De Raeve; Elke De Bruyne; Song Xu; Ben Van Camp; Damian Handisides; Charles P. Hart; Karin Vanderkerken.

doi:10.1158/1535-7163.MCT-15-0298

Erratum: Correction: Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Bortezomib and Hypoxia-Activated Prodrug TH-302, In Vivo and In Vitro (Mol Cancer Ther (2013) 12 (1763-73))

Jinsong Hu
, Els Van Valckenborgh
, Dehui Xu
, Eline Menu
, Hendrik De Raeve
, Elke De Bruyne
, Song Xu
, Ben Van Camp
, Damian Handisides
, Charles P. Hart
, Karin Vanderkerken.

School of Electrical Engineering

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	1762
Number of pages	1
Journal	Molecular Cancer Therapeutics
Volume	14
Issue number	7
DOIs	https://doi.org/10.1158/1535-7163.MCT-15-0298
State	Published - 1 Jul 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1535-7163.MCT-15-0298

Cite this

Hu, J., Van Valckenborgh, E., Xu, D., Menu, E., De Raeve, H., De Bruyne, E., Xu, S., Van Camp, B., Handisides, D., Hart, C. P., & Vanderkerken., K. (2015). Erratum: Correction: Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Bortezomib and Hypoxia-Activated Prodrug TH-302, In Vivo and In Vitro (Mol Cancer Ther (2013) 12 (1763-73)). Molecular Cancer Therapeutics, 14(7), 1762. https://doi.org/10.1158/1535-7163.MCT-15-0298

@article{0d6e8eb8006e403dba06f1114bed55b1,

title = "Erratum: Correction: Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Bortezomib and Hypoxia-Activated Prodrug TH-302, In Vivo and In Vitro (Mol Cancer Ther (2013) 12 (1763-73))",

author = "Jinsong Hu and \{Van Valckenborgh\}, Els and Dehui Xu and Eline Menu and \{De Raeve\}, Hendrik and \{De Bruyne\}, Elke and Song Xu and \{Van Camp\}, Ben and Damian Handisides and Hart, \{Charles P.\} and Karin Vanderkerken.",

year = "2015",

month = jul,

day = "1",

doi = "10.1158/1535-7163.MCT-15-0298",

language = "英语",

volume = "14",

pages = "1762",

journal = "Molecular Cancer Therapeutics",

issn = "1535-7163",

publisher = "American Association for Cancer Research Inc.",

number = "7",

}

Hu, J, Van Valckenborgh, E, Xu, D, Menu, E, De Raeve, H, De Bruyne, E, Xu, S, Van Camp, B, Handisides, D, Hart, CP & Vanderkerken., K 2015, 'Erratum: Correction: Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Bortezomib and Hypoxia-Activated Prodrug TH-302, In Vivo and In Vitro (Mol Cancer Ther (2013) 12 (1763-73))', Molecular Cancer Therapeutics, vol. 14, no. 7, pp. 1762. https://doi.org/10.1158/1535-7163.MCT-15-0298

Erratum: Correction: Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Bortezomib and Hypoxia-Activated Prodrug TH-302, In Vivo and In Vitro (Mol Cancer Ther (2013) 12 (1763-73)). / Hu, Jinsong; Van Valckenborgh, Els; Xu, Dehui et al.
In: Molecular Cancer Therapeutics, Vol. 14, No. 7, 01.07.2015, p. 1762.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - Correction: Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Bortezomib and Hypoxia-Activated Prodrug TH-302, In Vivo and In Vitro (Mol Cancer Ther (2013) 12 (1763-73))

AU - Hu, Jinsong

AU - Van Valckenborgh, Els

AU - Xu, Dehui

AU - Menu, Eline

AU - De Raeve, Hendrik

AU - De Bruyne, Elke

AU - Xu, Song

AU - Van Camp, Ben

AU - Handisides, Damian

AU - Hart, Charles P.

AU - Vanderkerken., Karin

PY - 2015/7/1

Y1 - 2015/7/1

UR - https://www.scopus.com/pages/publications/84942121936

U2 - 10.1158/1535-7163.MCT-15-0298

DO - 10.1158/1535-7163.MCT-15-0298

M3 - 评论/辩论

AN - SCOPUS:84942121936

SN - 1535-7163

VL - 14

SP - 1762

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

IS - 7

ER -

Erratum: Correction: Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Bortezomib and Hypoxia-Activated Prodrug TH-302, In Vivo and In Vitro (Mol Cancer Ther (2013) 12 (1763-73))

UN SDGs

Access to Document

Other files and links

Cite this